… on rash development were observed. We comprehensively investigated erlotinib-induced
skin rash biomarkers … Erlotinib is distributed into peripheral organs such as bone marrow and …

… with metastatic pancreatic carcinoma were treated with gemcitabine/erlotinib (Tarceva®)
based on the decision of the treating physician. Data were collected before the initiation of the …

… It is generally distributed in the seborrheic areas, where … one of them developed a rash (50%
of total patients), but we … reported in three female patients treated with erlotinib, and one of …

… plasma metabolites that increased after erlotinib treatment in patients who had a skin rash.
Three patients developed a skin rash after receiving erlotinib treatment, and their metabolite …

… base that are mainly distributed in the trunk and … adverse skin effects: acneiform rash (63%),
dry skin (7.7%), pruritus (3.8%), and paronychia (6.0%) [13]. Erlotinib-related acneiform rash …

… , became more distributed and were associated with moderate pruritus and pain. The …
erlotinib treatment. Cutaneous side effects of protein kinase inhibitors, such as maculopapular rash…

… Acneiform rash during lung cancer therapy with erlotinib (Tarceva®). Poste py Dermat
Alergol … Erlotinib-induced skin rash in patients with non-small-cell lung cancer: Pathogenesis, …

… That is, erlotinib-related skin rash and diarrhea have been evaluated carefully based on the
clinical application and studies and how to manage about the adverse events are also well …

… treatment, erlotinib serum concentrations were measured, and the dose was accordingly
adjusted. The erlotinib dose required to reduce toxicity (rash … were V (volume of distribution, L), …

… many patients complain of an acneiform rash or dry skin during … using erlotinib to clarify the
mechanism of dry skin caused by … levels and distribution of aquaporin (AQP) in mouse skin. …